Skip to content

Kluwer Patent Blog

Kluwer Patent Blog
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
(Indirect) infringement, Account of profits, Case Law, Damages, France

Waters v. Agilent et al., Court of First Instance Paris (Tribunal de Grande Instance Paris), 14 Januari 2009

Bruno Weil/January 14, 2009

This case provides a rather complete example of how to calculate damages in a patent infringement action in France. When the patent owner directly works out his patent in France, damages are based on lost profits and completed by additional royalties if the lost profits are below the amount of total infringing sales. When the patent owner does not directly work out his patent or cannot provide the information of production costs to calculate the margin of profits, damages are based on royalties. The infringer is held to pay springboard damages if, after the termination of the infringements, he continues profiting from the commercial advantages remaining from the infringing sales.

 


_____________________________

To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.


Kluwer IP Law

The 2022 Future Ready Lawyer survey showed that 79% of lawyers think that the importance of legal technology will increase for next year. With Kluwer IP Law you can navigate the increasingly global practice of IP law with specialized, local and cross-border information and tools from every preferred location. Are you, as an IP professional, ready for the future?

Learn how Kluwer IP Law can support you.

Kluwer IP Law
This page as PDF
Like? Share with your friends.FacebookTwitterLinkedInEmail

Post navigation

Next Article

Data processing method, Federal Court of Justice (Bundesgerichtshof), 20 January 2009

Anja Lunze/January 20, 2009

Get Blog Posts in your Inbox!

Go to posts on

(Compulsory) license (Cross-border) jurisdiction (Indirect) infringement Amendments Biologics Brexit Case Law Chemical Engineering Damages Denmark Enforcement EPC EPO EPO Decision Equivalents European Union Exceptions to patentability Extent of Protection France Germany Infringement Injunction Inventive step Italy Litigation Netherlands Novelty Opposition Patents Pharma Pharmaceutical patent Procedure Revocation Scope of protection Second Medical Use SEP Spain SPC Sufficiency of disclosure Switzerland Unitary Patent United Kingdom United States of America UPC Validity

Number 3 in Top 10 Pharma Patent Blogs To Follow in 2022!

Pharma Patent Blogs

Blog Contributors

  • Brian Cordery
    Bristows
  • Rik Lambers
    Brinkhof
  • Daniela Ampollini
    Trevisan & Cuonzo
  • Thorsten Bausch
    Hoffmann Eitle
  • John Collins
    Clayton Utz
  • Matthieu Dhenne
    Ipsilon
  • Simon Holzer
    MLL Meyerlustenberger Lachenal Froriep Ltd.
  • Binxin Li
    Baker & McKenzie FenXun (FTZ)
  • Vaishali Mittal
    Anand and Anand
  • Miquel Montañá
    Clifford Chance
  • Roberto Rodrigues Pinho
    Licks Attorneys
  • Alexa von Uexküll
    Vossius & Partner
  • Anders Valentin
    Bugge Valentin
VAEPC-2021Vissers Annotated European Patent Convention 2022 EditionKaisa Suominen, Peter de Lange, Andrew Rudge€ 105
10059161-0002_OR2_290_1669279860815Guide to EU and UK Pharmaceutical Regulatory Law, Eighth EditionSally Shorthose€ 265
10091699-0001_OR2_290_1655873530857The Digital Economy and International Trade: Transnational Data Flows RegulationRobert Walters€ 139

Kluwer IP Law News Alert

Stay informed on Intellectual Property law & developments

Search Posts

RSS feeds

Summary Feed Article Feed

Related Sites

  • Kluwer IP Law
  • Kluwer Copyright Blog
  • Kluwer Trademark Blog
  • Regulating for Globalization Blog
  • Author Portal
Kluwer Logo

About us

  • About Kluwer Patent Blog
  • Kluwer IP Law
  • Kluwer Law International
  • E-store
  • Authors

Legal policy

  • User Agreement and Disclaimer
  • Editorial Policy & Guidelines
  • Privacy Policy and Use of Cookies

Contact

  • General Information
Back to top